Flutamide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00499 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 44 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | prostate cancer/brain cancer susceptibility | KG + DL |
| 2 | fibroma of prostate | KG + DL |
| 3 | Brenner tumor | KG + DL |
| 4 | benign reproductive system neoplasm | KG + DL |
| 5 | prostate leiomyoma | KG + DL |
| 6 | male reproductive organ cancer | KG + DL |
| 7 | benign prostate phyllodes tumor | KG + DL |
| 8 | HIV infectious disease | KG + DL |
| 9 | feline acquired immunodeficiency syndrome | KG + DL |
| 10 | simian immunodeficiency virus infection | KG + DL |
| 11 | female breast carcinoma | KG + DL |
| 12 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 13 | breast fibrocystic disease | KG + DL |
| 14 | benign mammary dysplasia | KG + DL |
| 15 | malignant prostate phyllodes tumor | KG + DL |
| 16 | AIDS | KG + DL |
| 17 | blunt duct adenosis of breast | KG + DL |
| 18 | apocrine adenosis of breast | KG + DL |
| 19 | estrogen-receptor negative breast cancer | KG + DL |
| 20 | hormone-resistant breast carcinoma | KG + DL |
| 21 | Ehrlich tumor carcinoma | KG + DL |
| 22 | estrogen-receptor positive breast cancer | KG + DL |
| 23 | bilateral breast carcinoma | KG + DL |
| 24 | fat necrosis of breast | KG + DL |
| 25 | breast abscess | KG + DL |
| 26 | breast carcinoma by gene expression profile | KG + DL |
| 27 | breast adenosis | KG + DL |
| 28 | lactation disease | KG + DL |
| 29 | congenital human immunodeficiency virus | KG + DL |
| 30 | AIDS related complex | KG + DL |
| 31 | prostate phyllodes tumor | KG + DL |
| 32 | benign neoplasm of prostate | KG + DL |
| 33 | nipple carcinoma | KG + DL |
| 34 | obsolete familial combined hyperlipidemia | KG + DL |
| 35 | palmoplantar keratoderma-sclerodactyly syndrome | KG + DL |
| 36 | peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome | KG + DL |
| 37 | primitive portal vein thrombosis | KG + DL |
| 38 | hepatoportal sclerosis | KG + DL |
| 39 | hepatopulmonary syndrome | KG + DL |
| 40 | idiopathic copper-associated cirrhosis | KG + DL |
| 41 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 42 | hepatic porphyria | KG + DL |
| 43 | collagenopathy | KG + DL |
| 44 | lymphocytic hypereosinophilic syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.